chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Awoke w/ throat discomfort which quickly turned to several flu-type symptoms: muscle ache and weakness, tightness in chest, fever, fatigue, general weakness, brief headache and brief itchy rash.  Except for headache and rash, the symptoms were significant for 2 days, lessening on 3rd day, however then dry cough and hoarseness started and persisted for 10 days, accompanied by some nasal discharge.
KILLED THEMSELVES; ADVERSE EVENT NOS; TREMENDOUS PAIN; This spontaneous report received from a consumer concerned multiple patients (27 patients).  The patient's weight, height, and medical histories were not reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose, start therapy dates were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patients killed themselves because of adverse event to vaccines (coded as adverse event nos) and had tremendous pain daily. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of tremendous pain and adverse event nos was not reported. This report was serious (Death). This case, from the same reporter is linked to 20221134051.; Sender's Comments: V0- 20221134487-Covid-19 vaccine ad26.CoV-2.s. -Killed themselves -The event has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable; Reported Cause(s) of Death: SUICIDE
Development of tetanus after recieving covid 19 vaccine symptoms include jaw contraction stomach spasm fever severe neck pain, facial spasms
This spontaneous report was received from a physician and a medical assistant concerning an 18 year old patient of an unknown gender. Concurrent conditions, medical history and allergies were not reported. On 30-MAR-2014, the patient was vaccinated with a dose of GARDASIL (strength, dose, frequency, route and anatomical location were not reported)(lot #K006124, expiration date: 02-FEB-2017) that was improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Second does received 5-13-21 10:15 a.m. symptoms after first shot:  shortness of breath, chest pain, chest tightness, extreme fatigue, lack of appetite.  After 2nd vaccine the symptoms got 200% worse about 3 days after the 2nd vaccine.  Lingering symptoms still continue today.
Janssen COVID-19 Vaccine EUA Sore arm, woke up at 1:00am with chills but no fever. I went back to sleep. When I got up at 5:40am, I had a headache and my body was aching. I took ibuprofen. After a few hours, those symptoms are much milder.
I had every single side effect listed.  Severe headache starting almost immediately, lasting 5 days.  Fever of 102, gradually coming down, over 5 days.  Severe dry coughing, lasting 6 days and continuing. Severe muscle aches, lasting 6 days so far. Diarrhea lasting 1 day.  Nausea, lasting 3 days.
headache, cough, fever, shortness of breath, runny nose. starting 12/26/21
First vaccine: Jaw, neck, upper back pain on the left side 30 min following injection. Had to seek help from a kinesiologist to clear my system (heart and liver)of allergic reaction. Second vaccine: immediate brain fog-out of body experience, numbness of left ring and pinky fingertips, mild numbness left side of face primarily around the lips/chin followed by inability to take a full deep breath after 30 min.  Had to see help again from a kinesiologist to clear my system (all organs) of allergic reaction.
After sitting for five minutes after the Pfizer Covid vaccine, patient reports feeling lightheaded and may have had a brief loss of consciousness episode.  Per mom, patient's eyes widened briefly before returning to normal.  Patient was gently laid onto the ground.  Was initially confused, but soon was alert and oriented x 3.  Was talking in full sentences.  911 was called.  Patient was doing well  when the paramedics came.
DEATH; This spontaneous report received from a pharmacist concerned a male of an unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported,1 total, administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient who received the JANSSEN COVID-19 vaccine and passed away a few weeks later. It was not sure whether his other medical issues contributed to his death. The patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: - COVID-19 VACCINE AD26.COV2.S - Death, This event is considered Unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Chills; Lost of bowl control. Urinated and defecated; Fell to floor couldn't get off floor; Dizzy; Weakness; This is a spontaneous report from a contactable consumer, the patient.   A 72-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: Unknown) via an unspecified route of administration in the left arm on 12Mar2021 at 0000hours (at the age of 72-years-old), as a second single dose for COVID-19 immunisation at hospital. The patient's medical history included hypertension and type 2 diabetic. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Not known), via an unspecified route of administration on an unspecified date, for COVID-19 immunisation. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  On 13Mar2021 at 02:00 hours, the patient experienced chills, followed by weakness and dizziness. He fell to floor and couldn't get off the floor and he lost bowel control, urinated and defecated. He did not receive any treatment for adverse events. The clinical outcome of the events chills, weakness, dizzy, fall and bowel incontinence was recovering. No follow up attempts are possible; information about batch number cannot be obtained.
Fatigue, nausea, low grade fever (under 100*F), chills lasting 24 hours
23 yo F who is fully vaccinated with the COVID vaccine on 5 May 2021.  2 weeks later developed dermatitis treated with antihistamines and subsequently polyarthralgias (back/leg/knee pain) treated with steroids. Rheum workup negative. Dx likely transient tenosynovitis.  Patient is better now.
Arm Pain; Fatigue; Pyrexia; Head Ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), FATIGUE (Fatigue), PYREXIA (Pyrexia) and HEADACHE (Head Ache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), FATIGUE (Fatigue), PYREXIA (Pyrexia) and HEADACHE (Head Ache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 18-Feb-2021, PAIN IN EXTREMITY (Arm Pain), FATIGUE (Fatigue), PYREXIA (Pyrexia) and HEADACHE (Head Ache) had resolved.            Concomitant information were not provided by the reporter. The patient was self medicated to treat her symptoms.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
stated she felt like she has cotton balls in her throat, and that was the same feeling she had when she had her allergic reaction to Gain detergent.
Child complained of headache and sore throat, within 10-15 minutes after receiving LAIV. Initially, had slight wheezing which increased and had stridor. EPIPEN given at 9:35 a.m. and 911 called. Within few minutes, stridor subsided and breathing improved.
pt recvd vax; to MD for swelling , pain, redness lt upper arm p/ vax; seen on 23jan96 w/ improvement
A non-serious spontaneous report of upper lip numb has been received from a registered nurse concerning an adult male who is an EMS worked, subsequent to FLUMIST.  The patient's medical history and concomitant medications were not reported. The patient received FLUMIST on 19-Oct-2009 at the Fire Station. The morning of the following day after his vaccination, the patient woke up with his upper lip being completely numb. The outcome of the event was not reported.
Associate gave a Kinrix (DTAP,IPV) vaccine to a child that was 4 months old. Recommended age for this vaccination is 4 years and up.  Patient's Age  Infanct (greater than 28 day, less than 1 year)
This case was reported by a pharmacist and described the occurrence of not responding to therapy in a male subject of unspecified age who was vaccinated with HAVRIX (GlaxoSmithKline). On 6 January 2012 and 17 July 2012 the subject received 1st dose and 2nd dose of HAVRIX (unknown). At an unspecified time after vaccination with HAVRIX series, the subject experienced not responding to therapy. The subject had a titer performed on an unspecified date and showed non reactive. The healthcare professional reported several subjects did not respond to Hepatitis A vaccine; seven with HAVRIX and three with TWINRIX. For the other subjects please see OCEANS cases A0994236A, A0994238A- A0994242A, A0994244A, A0994246A.
Pt recvd 1st dose of vax on 7FEB92 & on 6MAR92 pt exp soreness in rt shoulder around inject site; 12MAR92 soreness persisted & was accompanied by burning sensation that radiated into shoulder; 13MAR92 PE by MD showed poss thickening of delt
Approximately one week after the second shot (March 29 or so) experienced sharp pains in left wrist and difficulty bending wrist.  Thought it might have been a bite some kind, but now, in retrospect, with a new rheumatoid arthritis diagnosis on May 7th, I realize it was the same pain I am now experiencing. A few days later I also experienced a stabbing flare of pain the my upper left arm at the site of a Shringix vaccination in 2019. The following morning there was a bright pink spot on the arm that subsequently developed into a shingles-like crusty scab. This appeared to be a flare up of shingles experienced in Jan. 2013.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned an 82 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: rare blood cancer (since 1995). The patient received covid-19 vaccine ad26.cov2.s (dose series 1) (suspension for injection, route of admin not reported, batch number: 1708609, expiry: UNKNOWN) dose was not reported, 1 total, administered at left arm in late afternoon between 16:00 or 17:00 on 23-MAR-2021 for prophylactic vaccination. Concomitant medications included special flu shot (influenza vaccine).  On 08-NOV-2021, the patient diagnosed with Covid-19, patient did not hospitalized or ventilated, stayed in bed at home. The patient was getting over quarantine as of 18-NOV-2021. On 08-NOV-2021, the patient's Covid test was done, took nose swab. The patient received results on 09-NOV-2021, who said his test was positive, and this results in confirmed clinical vaccination failure. On 08-NOV-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Positive. The patient just received his 2nd special flu shot and would like to get a Janssen Covid-19 vaccine booster. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the confirmed clinical vaccination failure and confirmed covid-19 infection was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000205266.; Sender's Comments: V0: 20211208454 -Covid-19 vaccine ad26.cov2.s- Confirmed clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.
Fever- Febrile seizure, seen at ED.  Treated with Tylenol, responded well.
first vaccine: injection site pain; first vaccine: weakness; first vaccine: body aches; This is a spontaneous report from a contactable consumer (patient). A 67-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EN5318, Expiry date was not reported) administered in hand right via an unknown route of administration on 09Feb2021 (at the age of 67 years old) as dose 1, single for covid-19 immunisation. Medical history included ongoing shellfish allergy. The patient's concomitant medications were not reported. The patient had not received any other medications within two weeks. The patient had not received any other vaccine within 4 weeks. The patient also received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EN6201, Expiry date was not reported) via an unspecified route of administration, administered in Hand Right on 02Mar2021 at 14:15 as dose 2, single for covid-19 immunisation. On 09Feb2021 at 18:00 (6 hours later), the patient experienced first vaccine: injection site pain, first vaccine: weakness, and first vaccine: body aches. It was reported that the events were stopped completely 24 hours. The outcome for the events first vaccine: injection site pain, first vaccine: weakness, and first vaccine: body aches was recovered on 10Feb2021. No follow-up attempts are possible; information about lot/batch no cannot be obtained.
No adverse event; improperly stored MMR II were administered; This spontaneous report as received from another health professional (medical assistant) referring to a patient of unknown age and gender. The patient's concurrent condition, pertinent medical history, concomitant therapies, and drug allergies and reactions were not reported.      On 28-SEP-2021, the patient was vaccinated with the temperate excursion vaccines of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (strength was not provided; lot# was T016197 and expiration date was 11-MAY-2022) for prophylaxis. The vaccine underwent a temperature excursion of 10.5 degree Celsius (C) to 8.5 C for a period of 6 hours and 46 minutes and 1 hour and 24 minutes. The vaccine did not undergo a previous temperature excursion. The patient did not experience any adverse event.  This was one of two reports received from the same reporter.  ; Sender's Comments:  US-009507513-2109USA007381:
I woke up while sleeping to tightening of the muscle in my throat which restricted my ability to breathe.  It was similar feeling to getting a bee bite.  The difference being that the throat constriction started at the top of my throat and moved downward.  As the sensation moved downward, the muscles at the top eased up rather than staying restricted.  It last about 2 hours.
Extreme bout of peripheral neuropathy that lasted 4 days - still occurring Brain fog  that lasted 3 days
white (shocky appearance), floppy; dec motor coordination; screaming most noc;
Covid + on 10/26/2021. Received Moderna vaccine with 1st dose on 02/18/2021 and 2nd dose on 03/18/2021. Patient admitted into hospital on 10/19/2021  Per H & P: HISTORY OF PRESENT ILLNESS:  The patient is an 80-year-old female with  known history of stage IV poorly differentiated nonsmall cell lung  carcinoma, favoring squamous cell type, diagnosed in 02/2020.  She  presented with back pain.  Workup showed lytic lesion at L3 with mild acute  pathologic compression fracture and multiple bilateral lung nodules, right  lower leg, mediastinal, hilar adenopathy and rib metastasis.  She then had  a PET scan on 02/23 which showed abnormal metabolism in the root of the  mesentery and abdominal retroperitoneal with some projecting into the small  bowel.  MRI of the brain on 02/21/2021 was negative.  She underwent  chemotherapy with Taxol carbo Keytruda with improvement of the disease  burden on restaging scans in June and back pain improved as well.  She is  currently on Keytruda maintenance.  The patient was seen by neurosurgery as  well as radiation oncology.  She then developed perforation, was found to  have ischemic colitis, underwent colectomy and eventually transferred to  inpatient rehabilitation. While on the inpatient rehab unit, she had persistent nausea and vomiting,  which the initial AAS was negative.  She was given anti-emetics and PPI, but  the nausea and vomiting persisted.  Then the output from the ostomy decreased,  although her oral intake was poor.  Per ID Note:  Assessment and Plan  Positive rapid COVID-19 test in patient that has been fully vaccinated and is asymptomatic.  This could certainly be a false positive result  Status post subtotal colectomy for colonic perforation and peritonitis  Lung cancer with skeletal metastases on immunotherapy   Recommendations: I have ordered COVID-19 by PCR to determine if previous test was positive false positive.  In the meantime maintain isolation precautions.  If COVID-19 testing is truly positive one could consider monoclonal antibody treatment as certainly she would be at some risk for progression.  The patient is ready for discharge from an Infectious Disease standpoint. Yes [ _ ]    No [ _ ]  Subjective     She has occasional cough but she thinks is going well.  No chest pain or abdominal pain.  No shortness of breath.  No fevers.  Objective  The patient was going to be transferred to the rehabilitation unit and she was tested for COVID-19 and the rapid test was positive.  She is fully vaccinated and she is basically asymptomatic.  Imaging and laboratory results reviewed.  White count is 4.3.  Creatinine 0.8.
18 yof, presented for her first dose of Pfzer on 09/02/21. Approximately 5 minutes after receiving the vaccine she stated, ?I feel dizzy?. Ice pack, water, juice, and gram crackers given to pt. 0901 Vitals: Temp: 97.0, BP 99/60, HR 62, Resp 16. Pt was diaphoretic; therefore, we lowered her to the floor and propped her feet up. She was fanned while laying down. 0908 she started to feel better. She ate some graham crackers and drank a little bit of juice. She did not eat breakfast today. She also reported that this happens every time she gets a shot. 0915 Temp 98.0, BP 118/70, HR 66, Resp 16. Pt was assisted to a nearby couch to finish out her observation period. 0940 Temp 98.1, BP 122/76, HR 74, and Resp 18. 0943 Pt feeling much better. She was instructed to rest, eat, and drink plenty of fluids. 0943 Pt left
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 07/23/2021. PATIENT FULLY VACCINATED ON 03/17/2021.
The pt experienced a swollen left arm with redness and warmth to the touch from shoulder to elbow.
Muscle aches, headache, Very sore arm where shot was given, Tired and weak. Generally feel bad all over. I hope it goes away soon.
24 hours later my body was aching, and I was very fatigued. A little less than a week after my shot my left lower eye lid started to twitch at around 5:00 pm. It has continued on every day. In addition, today 12/11/21 now my lips and jaw have started to twitch. This starting at around 3:30ish. It will come and go with about 10-15 minutes between each twitch.
Patient had fever starting night of 9/29/2018 and called pharamcy on 9/30 to ask what she can do for it. She had been already doing cold compresses and Tylenol she said. Said would follow up with her on 10/1. On 10/1 when spoke to her she said fever had broke (highest point was 102F). Said she now had a small rash around where vaccine where administered.
Fever of 102.5, headache, dizziness, slight nausea, stayed in bed for most of day after booster vaccine.
Expired dose administered to a patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to a patient) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033K21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to a patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to a patient) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Patient received 1st booster dose. Reporter stated no adverse events were reported by the patient after getting the vaccine.  Date the vial was initially stored in the refrigerator was reported as 27 Apr 2022. The vial not underwent any temperature excursions.  No treatment medication was reported.
This spontaneous report as received from a registered nurse refers to a 29 year old (reported as "Age: 29") female patient. No information on her medical history, concurrent conditions or concomitant drugs was reported. On 31-JUL-2014 the patient was vaccinated with a dose of expired MMR II lot # H011907, expiration date 03-JUL-2014, 0.5 ml, subcutaneously in the right arm. No adverse effects were noted by patient. The patient did not seek medical attention. Additional information has been requested.